People

Mateu-Gelabert-276x303
Pedro Mateu-Gelabert, PhD
CUNY Graduate School of Public Health and Health Policy - Associate Professor
Email: pedro.mateu-gelabert@sph.cuny.edu
Education
PhD, Sociology, New York University
BA, Sociology, Universidad Complutense, Madrid
Research Interests
Epidemiology of drug use, HIV/HCV prevention, Prescription opioid misuse, Overdose, HIV in Latin America, Urban ethnography
BIO
Pedro Mateu-Gelabert is an Associate Professor at the CUNY Graduate School of Public Health and Health Policy and a sociologist with over 20 years of research experience in New York City and internationally. His research spans the epidemiology of drug use, urban studies, crime, immigration, social networks, and HIV/Hepatitis C prevention. He has more than 50 peer-reviewed publications and has been guest lecturer in numerous national and international forums including University of Chicago, Columbia University, Beth Israel Medical Center, Colombian Ministry of Health, Rio de Janeiro Office of Public Safety, and Office of Human Rights in San José (Costa Rica). Dr. Mateu-Gelabert has collaborated with various interdisciplinary research teams, including the New York City Department of Health and Mental Hygiene (NYCDOHMH), Weill Cornell Medical College, and Beth Israel Medical Center. He has worked on international projects in multiple countries including Colombia (Emerging heroin markets leading to HIV epidemics among young injectors), Spain (HCV prevention among injection drug users) and Ukraine (HIV treatment access and care cascade for people who inject drugs).
Projects
Principal Investigator, Accessible Care Intervention for Engaging People Who Inject Illicit Drugs (PWID) in Hepatitis C Care. Completed
Principal Investigator, HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids. Completed
Principal Investigator, Staying Safe Intervention: Preventing HCV Among Youth Opioid Injectors. Completed
Principal Investigator, Staying Safe: Training IDUs in Strategies to Avoid HIV and HCV Infection. Completed
Publications

Recent

Bradley H, Luisi N, Carter A..., Hagan H..., Mateu-Gelabert P..., Des Jarlais DC (2024).
Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model
AIDS [Epub 2024 Nov 28]. doi: 10.1097/QAD.0000000000004076.

Lee CSJ, Mateu-Gelabert P, Aponte-Melendez Y, Fong C, Kapadia SN, Smith M, Marks KM, Eckhardt B (2024).
Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model
PLoS One, 19 (8), e0308102. doi: 10.1371/journal.pone.0308102. PMCID: PMC11361571.

Mateu-Gelabert P, Pratt S, Guarino H, Hallack R, Fong C, Eckhardt B (2024).
HCV prevalence and phylogenetic characteristics in a cross-sectional, community study of young people who inject drugs in New York City: Opportunity for and threats to HCV elimination
Health Science Reports, 7 (7), e2211. doi: 10.1002/hsr2.2211. PMCID: PMC11217018.

Jessell L, Mateu-Gelabert P, Guarino H, Fong C (2024).
Why young women who use opioids are at risk for rape: The impact of social vulnerabilities and sexually coercive drug using contexts
Violence Against Women, 50 (5), 1035-1052. doi: 10.1177/10778012221137921.

van Selm L, White TM, Picchio CA, Requena-Mendez A, Busz M, Perez Gayo R, Pouille A, Mateu-Gelabert P, Lazarus JV (2024).
A call to create integrated services to better address the needs of migrants who use drugs in Europe
Harm Reduction Journal, 21 (1), 9. doi: 10.1186/s12954-023-00923-6. PMCID: PMC10787965.

Dr. Mateu-Gelabert's Google Scholar Profile
Selected Press